Good afternoon :)
Place Order
Add to Watchlist

ANG Lifesciences India Ltd

ANG Share Price

34.490.32% (-0.11)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹45 cr, stock is ranked 3,676

Stock is 3.29x as volatile as Nifty

ANG Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹45 cr, stock is ranked 3,676

Stock is 3.29x as volatile as Nifty

ANG Performance & Key Metrics

ANG Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-3.640.59
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.696.410.79%

ANG Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

ANG Company Profile

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

PE Ratio
36.72
36.72
1Y Return
7.46%
7.46%
Buy Reco %
87.50
87.50
PE Ratio
22.80
22.80
1Y Return
0.08%
0.08%
Buy Reco %
73.33
73.33
PE Ratio
58.83
58.83
1Y Return
15.25%
15.25%
Buy Reco %
70.83
70.83
PE Ratio
18.89
18.89
1Y Return
1.76%
1.76%
Buy Reco %
55.17
55.17
PE Ratio
50.40
50.40
1Y Return
17.92%
17.92%
Buy Reco %
81.25
81.25
Compare with Peers

ANG Forecast

ANG Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

ANG

ANG

Income

Balance Sheet

Cash Flow

ANG Income Statement

ANG Income Statement

Loading...

Financial YearFY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue154.93355.20229.61146.8194.8694.85
Raw Materialssubtract140.12234.65156.08102.7995.1195.12
Power & Fuel Costsubtract6.146.504.15
Employee Costsubtract21.2923.9719.35
Selling & Administrative Expensessubtract18.7015.4912.85
Operating & Other expensessubtract5.623.12-1.39
Depreciation/Amortizationsubtract1.335.889.358.376.766.75
Interest & Other Itemssubtract3.529.4212.4811.418.698.68
Taxes & Other Itemssubtract3.1113.192.89-0.57-3.29-3.29
EPS4.7431.11-0.21-7.77-9.42-9.50
DPS0.800.000.000.000.00
Payout ratio0.000.030.000.000.000.00

ANG Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

Aug 14PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Oct 26PDF
Sep 6PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF

Investor Presentation

Jun 14PDF
FY 2018FY 2018

Annual report

PDF
 

ANG Stock Peers

ANG Past Performance & Peer Comparison

ANG Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
ANG Lifesciences India Ltd-3.640.59
Sun Pharmaceutical Industries Ltd36.725.540.96%
Cipla Ltd22.803.841.07%
Torrent Pharmaceuticals Ltd58.8314.810.18%

ANG Stock Price Comparison

Compare ANG with any stock or ETF
Compare ANG with any stock or ETF
ANG
Loading...

ANG Holdings

ANG Shareholdings

ANG Promoter Holdings Trend

ANG Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

ANG Institutional Holdings Trend

ANG Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ANG Shareholding Pattern

ANG Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.60%0.00%0.00%0.00%29.40%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

ANG Shareholding History

ANG Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

ANG Insider Trades & Bulk Stock Deals

ANG Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ANG stock

smallcases containing ANG stock

Looks like this stock is not in any smallcase yet.

ANG Events

ANG Events

ANG Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

ANG Dividend Trend

No dividend trend available

ANG Upcoming Dividends

ANG Upcoming Dividends

No upcoming dividends are available

ANG Past Dividends

ANG Past Dividends

Cash Dividend

Ex DateEx DateNov 2, 2021

Interim
Interim | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Nov 2, 2021

ANG Stock News & Opinions

ANG Stock News & Opinions

Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.06 crore in the March 2025 quarter

Net Loss of ANG Lifesciences India reported to Rs 2.06 crore in the quarter ended March 2025 as against net loss of Rs 3.65 crore during the previous quarter ended March 2024. Sales declined 55.55% to Rs 16.82 crore in the quarter ended March 2025 as against Rs 37.84 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 12.41 crore in the year ended March 2025 as against net loss of Rs 10.14 crore during the previous year ended March 2024. Sales declined 36.45% to Rs 92.85 crore in the year ended March 2025 as against Rs 146.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales16.8237.84 -56 92.85146.11 -36 OPM %-4.168.88 --2.446.61 - PBDT-2.47-0.29 -752 -8.94-0.60 -1390 PBT-3.89-2.34 -66 -15.70-8.97 -75 NP-2.06-3.65 44 -12.41-10.14 -22 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
ANG Lifesciences India to hold board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
ANG Lifesciences India Ltd leads losers in 'B' group

Adroit Infotech Ltd, Dynamic Cables Ltd, Archidply Decor Ltd and Kwality Pharmaceuticals Ltd are among the other losers in the BSE's 'B' group today, 20 March 2025.ANG Lifesciences India Ltd crashed 9.96% to Rs 26.57 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 94016 shares were traded on the counter so far as against the average daily volumes of 13382 shares in the past one month.Adroit Infotech Ltd tumbled 7.84% to Rs 13.64. The stock was the second biggest loser in 'B' group.On the BSE, 76506 shares were traded on the counter so far as against the average daily volumes of 5344 shares in the past one month.Dynamic Cables Ltd lost 7.42% to Rs 533.5. The stock was the third biggest loser in 'B' group.On the BSE, 30414 shares were traded on the counter so far as against the average daily volumes of 8951 shares in the past one month.Archidply Decor Ltd shed 7.31% to Rs 68.5. The stock was the fourth biggest loser in 'B' group.On the BSE, 112 shares were traded on the counter so far as against the average daily volumes of 238 shares in the past one month.Kwality Pharmaceuticals Ltd corrected 6.90% to Rs 652. The stock was the fifth biggest loser in 'B' group.On the BSE, 24717 shares were traded on the counter so far as against the average daily volumes of 14355 shares in the past one month.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 5.19 crore in the December 2024 quarter

Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales24.7318.55 33 OPM %-8.69-10.30 - PBDT-4.42-4.45 1 PBT-6.38-6.37 0 NP-5.19-5.93 12 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
ANG Lifesciences India schedules board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter

Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.8833.26 -1 OPM %6.964.99 - PBDT0.45-0.41 LP PBT-1.29-2.63 51 NP-2.09-2.32 10 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
ANG Lifesciences India to conduct board meeting

ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
ANG Lifesciences India to hold AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
ANG Lifesciences India to convene AGM

ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter

Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.4156.46 -67 OPM %-9.2311.58 - PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PL Powered by Capital Market - Live

10 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of ANG Lifesciences India Ltd (ANG) today?

    The share price of ANG as on 9th July 2025 is ₹34.49. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on ANG Lifesciences India Ltd (ANG) share?

    The past returns of ANG Lifesciences India Ltd (ANG) share are
    • Past 1 week: 14.83%
    • Past 1 month: 13.36%
    • Past 3 months: 19.89%
    • Past 6 months: -20.95%
    • Past 1 year: -33.13%
    • Past 3 years: -81.00%
    • Past 5 years: 145.39%

  3. What are the peers or stocks similar to ANG Lifesciences India Ltd (ANG)?
  4. What is the market cap of ANG Lifesciences India Ltd (ANG) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd (ANG) is ₹45.18 Cr as of 9th July 2025.

  5. What is the 52 week high and low of ANG Lifesciences India Ltd (ANG) share?

    The 52-week high of ANG Lifesciences India Ltd (ANG) is ₹62.75 and the 52-week low is ₹21.03.

  6. What is the PE and PB ratio of ANG Lifesciences India Ltd (ANG) stock?

    The P/E (price-to-earnings) ratio of ANG Lifesciences India Ltd (ANG) is -3.64. The P/B (price-to-book) ratio is 0.59.

  7. Which sector does ANG Lifesciences India Ltd (ANG) belong to?

    ANG Lifesciences India Ltd (ANG) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy ANG Lifesciences India Ltd (ANG) shares?

    You can directly buy ANG Lifesciences India Ltd (ANG) shares on Tickertape. Simply sign up, connect your demat account and place your order.